New oral drug aims to slow Alzheimer's in its earliest stages

NCT ID NCT07027072

Recruiting now Disease control Sponsor: NeuroBiogen Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental oral drug called KDS2010 in people with mild cognitive impairment or mild dementia due to Alzheimer's disease. Participants take either a low dose, a higher dose, or a placebo daily for 24 weeks. Researchers measure changes in memory, thinking, and daily living skills, along with blood and spinal fluid biomarkers, to see if the drug can slow disease progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: KDS2010
What this could lead to: If effective, KDS2010 could slow memory loss and daily function decline in early Alzheimer's, offering a new oral treatment option.
What could go wrong: This is an early Phase 2a dose-finding study with only 114 people. It may fail to show benefit or have side effects not yet seen in Phase 1.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER'S DISEASE MILD COGNITIVE IMPAIRMENT (MCI) MILD DEMENTIA

Contacts and locations

Locations

Ajou University Hospital
RECRUITING

Suwon, Gyeonggi-do, 16499, South Korea
Asan Medical Center
RECRUITING

Seoul, Seoul, 05505, South Korea
Chonnam National Unversity Hospital
RECRUITING

Gwangju, Gwangju, 61469, South Korea
Gachon University Gil Medical Center
RECRUITING

Incheon, Incheon, 21565, South Korea
Hanyang University Guri Hospital
RECRUITING

Guri-si, Gyeonggi-do, 11923, South Korea
Hanyang University Seoul Hospital
RECRUITING

Seoul, Seoul, 04763, South Korea
Konkuk University Medical Center
RECRUITING

Seoul, Seoul, 05030, South Korea
The Catholic University of Korea St. Vincent's Hospital
RECRUITING

Suwon, Gyeonggi-do, 16247, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.